Although the targets of glioblastoma are uncertain, our study established that Dcf1 is a potential suppressor and candidate target for glioblastoma treatment with both genetic and biological evidence, providing new information with which to understand mitochondrial function, autophagy, and lysosomal function in glioblastoma pathology. The gene discussed is TMEM59; the disease is glioblastoma.